(Q113892127)
Statements
A Multi-center, Randomized, Placebo-controlled, Double-blind, Cross-over, Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea (English)
0 references
30 September 2020
0 references
30 August 2021
0 references
120
0 references
19 year
0 references
44 year
0 references